A rectal gastrointestinal stromal tumor case accompanied by elevated CEA mimicking rectal carcinoma on 18F-FDG PET/CT

被引:0
作者
Tao, Zihao [1 ]
Wu, Sitong [1 ]
Chen, Zhao [1 ]
Qiu, Yongkang [1 ]
Song, Lele [1 ]
Yang, Qi [1 ]
Nong, Lin [2 ]
Kang, Lei [1 ]
机构
[1] Peking Univ First Hosp, Dept Nucl Med, Beijing 100034, Peoples R China
[2] Peking Univ First Hosp, Dept Pathol, Beijing 100034, Peoples R China
关键词
Gastrointestinal stromal tumor; GIST; rectum; F-18-FDG; PET/CT; case report; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; IMATINIB MESYLATE; FDG-PET; GIST; THERAPY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm arising from gastrointestinal tract and can be benign or malignant. Rectal GISTs are rare and have poor prognosis. We here reported an older male who presented with features of distending discomfort in the rectum and pain in the anus due to a large rectal tumor. Physical examinations detected a mass in the rectum without blood staining on the gloved finger. Carcinoembryonic antigen (CEA) was found to be slightly elevated and the prostate-specific antigen level was normal. F-18-FDG PET/CT showed a soft tissue density mass at the bottom of the pelvic, with an unclear boundary to the surroundings with the significantly increased FDG uptake (SUVmax 17.5). Although a rectal carcinoma was suspected based on the finding of PET/CT and CEA, the histopathological examination confirmed the diagnosis of the malignant GIST of the rectum. The patient was then treated with imatinib and on follow-up regularly. In this case, F-18-FDG PET/CT shows the advantage of visualizing both primary and metastatic lesions and provides valuable information for the diagnosis, staging, evaluation, and prognosis of GIST.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 24 条
[1]   Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate [J].
Abhyankar, Suman A. ;
Nair, Narendra .
CLINICAL NUCLEAR MEDICINE, 2008, 33 (03) :213-214
[2]  
Antoch G, 2004, J NUCL MED, V45, P357
[3]   FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor [J].
Basu, Sandip ;
Mohandas, Kunissery Mallath ;
Peshwe, Harish ;
Asopa, Ramesh ;
Vyawahare, Manoj .
NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (12) :1026-1039
[4]   Malignant gastrointestinal stromal tumor: Distribution, imaging features, and pattern of metastatic spread [J].
Burkill, GJC ;
Badran, M ;
Al-Muderis, O ;
Thomas, JM ;
Judson, IR ;
Fisher, C ;
Moskovic, EC .
RADIOLOGY, 2003, 226 (02) :527-532
[5]   Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].
Choi, Haesun ;
Charnsangavej, Chuslip ;
Faria, Silvana C. ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Benjamin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759
[6]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[7]  
Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1
[8]  
[邓燕云 Deng Yanyun], 2014, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V30, P881
[9]  
Expert Committee of Clinical Practice Guideline for the Pathological Diagnosis of Gastrointestinal Stromal Tumor (2022 version), 2022, Zhonghua Bing Li Xue Za Zhi, V51, P959, DOI 10.3760/cma.j.cn112151-20220512-00405
[10]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2002, 10 (02) :81-89